Browsing Tag
Nestlé Health Science
10 posts
HLN share price firms as Sensodyne and Centrum drive Haleon’s 2026 organic growth recovery
Sensodyne grows 8%. Centrum targets GLP-1 users. The £500m buyback erases shares at sub-340p. Haleon's recovery hinges on Q2 cold and flu normalising.
Men’s hair loss breakthrough? Garden of Life unveils game-changing supplements for hair regrowth and digestive health
Discover how Garden of Life’s new Dr. Formulated supplements are tackling men’s hair loss with science-backed ingredients like Actrisave® and probiotics.
Nestlé Health Science to acquire VOWST assets from Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) has announced a significant development in its partnership with Nestlé Health Science—a non-binding…
Seres Therapeutics gets FDA priority review designation for SER-109 in rCDI
Seres Therapeutics has secured priority review designation from the US Food and Drug Administration (FDA) for SER-109, its…
Butterfly to sell majority stake in Orgain to Nestlé Health Science
Private equity firm Butterfly has signed a deal to divest a majority stake in Orgain, a plant-based functional…
Nestlé to acquire core brands of vitamins manufacturer Bountiful for $5.7bn
Nestlé has signed a deal worth $5.75 billion with KKR to acquire core brands of Bountiful, a US…
Seres Therapeutics begins Phase 1b trial for SER-301 in active ulcerative colitis
Seres Therapeutics, a prominent US-based biotech company, has announced the commencement of dosing in a Phase 1b clinical…
Nestlé to fully own Aimmune Therapeutics through $2bn deal
Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by…
Nestlé to acquire majority stake in US collagen brand Vital Proteins
Nestlé Health Science (NHSc) has agreed to acquire a majority stake in Vital Proteins, a US collagen brand…
Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval
Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut…